JENNIFER E SMITH PA
Prescription History 1811260821
Physician Assistant in Oklahoma City, OK
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JENNIFER E SMITH PA, an active Physician Assistant specialist practicing in Oklahoma City, OK. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 255 documented patient claims. Among these therapy options, the most frequently utilized medication is Gabapentin, which accounts for 79 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other OK PrescribersVs. OK Avg |
|---|---|---|---|
| Gabapentin | 79 | $22.35▼ below OK avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 79 Medicare prescriptions for Gabapentin, about 69% of the volume of the typical Oklahoma prescriber of this medication (114). Medicare paid an average of $22.35 per fill, versus $22.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 149.7 30-Day Fills standardized to 30-day supplies 4,490 Days of Medication total across all patients in 2023 | |||
| Baclofen | 36 | $35.26 | ≈ Typical |
About Baclofen: Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). Show more ▾ It works by helping to relax the muscles. A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission. In 2023, this provider wrote 36 Medicare prescriptions for Baclofen, about 84% of the volume of the typical Oklahoma prescriber of this medication (43). Medicare paid an average of $35.26 per fill, versus $28.17 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 71.5 30-Day Fills standardized to 30-day supplies 2,145 Days of Medication total across all patients in 2023 | |||
| Solifenacin Succinate | 23 | $174.10 | ▼ Less than typical |
About Solifenacin Succinate: Solifenacin is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, solifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE. In 2023, this provider wrote 23 Medicare prescriptions for Solifenacin Succinate, about 72% of the volume of the typical Oklahoma prescriber of this medication (32). Medicare paid an average of $174.10 per fill, versus $92.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 52 30-Day Fills standardized to 30-day supplies 1,560 Days of Medication total across all patients in 2023 | |||
| Tizanidine Hcl | 17 | $12.41▼ below OK avg | ▼ Less than typical |
About Tizanidine Hcl: This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). Show more ▾ It works by helping to relax the muscles. In 2023, this provider wrote 17 Medicare prescriptions for Tizanidine Hcl, about a third of the volume of the typical Oklahoma prescriber of this medication (55). Medicare paid an average of $12.41 per fill, versus $15.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 36.7 30-Day Fills standardized to 30-day supplies 1,100 Days of Medication total across all patients in 2023 | |||
| Kesimpta PenOfatumumab | 16 | $10,434.85 | ≈ Typical |
About Kesimpta Pen: Ofatumumab is used to treat a certain type of cancer (chronic lymphocytic leukemia - CLL). Show more ▾ Ofatumumab belongs to a class of drugs known as monoclonal antibodies. This medication works by stopping the growth of cancer cells. In 2023, this provider wrote 16 Medicare prescriptions for Kesimpta Pen, about 76% of the volume of the typical Oklahoma prescriber of this medication (21). Medicare paid an average of $10,434.85 per fill, versus $9,378.96 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 530 Days of Medication total across all patients in 2023 | |||
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $14.74▼ below OK avg | ▼ Less than typical |
About Oxybutynin Chloride Er: This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. Show more ▾ It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida). In 2023, this provider wrote 16 Medicare prescriptions for Oxybutynin Chloride Er, about half the volume of the typical Oklahoma prescriber of this medication (31). Medicare paid an average of $14.74 per fill, versus $41.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2023 | |||
| Duloxetine Hcl | 15 | $65.56 | ▼ Less than typical |
About Duloxetine Hcl: Duloxetine is used to treat depression and anxiety. Show more ▾ In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA. In 2023, this provider wrote 15 Medicare prescriptions for Duloxetine Hcl, about a quarter of the volume of the typical Oklahoma prescriber of this medication (57). Medicare paid an average of $65.56 per fill, versus $48.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2023 | |||
| Escitalopram Oxalate | 15 | $7.07▼ below OK avg | ▼ Less than typical |
About Escitalopram Oxalate: Escitalopram is used to treat depression and anxiety. Show more ▾ It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder. In 2023, this provider wrote 15 Medicare prescriptions for Escitalopram Oxalate, about a quarter of the volume of the typical Oklahoma prescriber of this medication (58). Medicare paid an average of $7.07 per fill, versus $14.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2023 | |||
| NuedextaDextromethorphan Hbr/Quinidine | 14 | $2,153.12 | ▼ Less than typical |
About Nuedexta: This medication is used to treat a certain mental/mood disorder (pseudobulbar affect). Show more ▾ This disorder may occur due to various conditions that affect the brain (such as stroke, amyotrophic lateral sclerosis-ALS, multiple sclerosis). This medication may help decrease sudden outbursts of uncontrollable/inappropriate laughing and/or crying. This medication is a combination of 2 ingredients: dextromethorphan and quinidine. Dextromethorphan works in the brain, though it is not known exactly how it helps treat pseudobulbar affect. Quinidine is added to this medication to increase the effect of dextromethorphan. In 2023, this provider wrote 14 Medicare prescriptions for Nuedexta, about a quarter of the volume of the typical Oklahoma prescriber of this medication (56). Medicare paid an average of $2,153.12 per fill, versus $827.77 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26 30-Day Fills standardized to 30-day supplies 781 Days of Medication total across all patients in 2023 | |||
| MyrbetriqMirabegron | 13 | $898.23 | ▼ Less than typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. In 2023, this provider wrote 13 Medicare prescriptions for Myrbetriq, about a third of the volume of the typical Oklahoma prescriber of this medication (42). Medicare paid an average of $898.23 per fill, versus $617.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2023 | |||
| VesicareSolifenacin Succinate | 11 | $433.02 | ≈ Typical |
About Vesicare: Solifenacin is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, solifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE. In 2023, this provider wrote 11 Medicare prescriptions for Vesicare, about the same volume as the typical Oklahoma prescriber of this medication (12). Medicare paid an average of $433.02 per fill, versus $419.16 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for JENNIFER E SMITH PA is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Oklahoma City, OK practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among OK prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
